Endometriosis: immunomodulation
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Endometriosis
- Focus Pharmacodynamics
- 17 Oct 2012 Biomarkers information updated
- 16 Oct 2012 Planned end date changed from 1 Jan 2010 to 1 May 2008 as reported by ClinicalTrials.gov.
- 31 Aug 2010 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.